hotspot -WSS

hotspot

author：knowledge 2025-09-27 22:59:39 - browse：67

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： The United States must get value

leisure time

WSS

Hottest summer in 2,000 years puts focus on extreme heat, health

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Advances in CAR

Galapagos to make CAR

The United States must get value

Humana sues Biden admin over Medicare Advantage audit rule

explore

hotspot

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Drug repurposing or repositioning? The language matters

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Medicare details structure of new drug price negotiation program

The United States must get value

Psychedelics group wrestles with new pharma identity

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

HHS suspends federal funding for EcoHealth Alliance

Trump demands the U.S. pay no more for drugs than other countries … again

What American doctors can learn from their Israeli counterparts

focus

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

'Make People Better': The CRISPR babies story you probably don't know

Oak Street deal isn't the answer to health care's woes

Trump surgeon general acknowledges mistakes during Covid

House transparency, PBM reform bill gains bipartisan support

A rare thyroid diagnosis led to unexpected, all

hotspot

hotspot

leisure time

hotspot